Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Lilly Considers Insulin Expansion

by Ann M. Thayer
April 8, 2013 | A version of this story appeared in Volume 91, Issue 14

Eli Lilly & Co. is evaluating a $180 million investment in its insulin manufacturing operations in Indianapolis. By March 2014, the firm intends to increase its active ingredient capacity by boosting productivity. It also will add a second insulin-cartridge filling line by 2016. The plan is on top of a $140 million expansion that the firm announced in late 2012. Lilly expects the new expansion to require about 170 construction workers and eventually 175 full-time technicians, scientists, and engineers. The company is considering other projects totaling about $80 million, including a $40 million product inspection center.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.